⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for diffuse large cell nhl

Every month we try and update this database with for diffuse large cell nhl cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHLNCT01101581
Non Hodgkin's L...
NHL
Aggressive NHL
Diffuse Large B...
Veltuzumab and ...
90Y-epratuzumab...
veltuzumab
18 Years - Gilead Sciences
Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHLNCT01101581
Non Hodgkin's L...
NHL
Aggressive NHL
Diffuse Large B...
Veltuzumab and ...
90Y-epratuzumab...
veltuzumab
18 Years - Gilead Sciences
Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHLNCT01101581
Non Hodgkin's L...
NHL
Aggressive NHL
Diffuse Large B...
Veltuzumab and ...
90Y-epratuzumab...
veltuzumab
18 Years - Gilead Sciences
Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHLNCT01101581
Non Hodgkin's L...
NHL
Aggressive NHL
Diffuse Large B...
Veltuzumab and ...
90Y-epratuzumab...
veltuzumab
18 Years - Gilead Sciences
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: